Your browser doesn't support javascript.
loading
Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.
Mai, Phuong L; Sand, Sharon R; Saha, Neiladri; Oberti, Mauricio; Dolafi, Tom; DiGianni, Lisa; Root, Elizabeth J; Kong, Xianhua; Bremer, Renee C; Santiago, Karina M; Bojadzieva, Jasmina; Barley, Derek; Novokmet, Ana; Ketchum, Karen A; Nguyen, Ngoc; Jacob, Shine; Nichols, Kim E; Kratz, Christian P; Schiffman, Joshua D; Evans, D Gareth; Achatz, Maria Isabel; Strong, Louise C; Garber, Judy E; Ladwa, Sweta A; Malkin, David; Weitzel, Jeffrey N.
Afiliación
  • Mai PL; Center for Medical Genetics and Genomics, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Sand SR; City of Hope National Medical Center, Duarte, California.
  • Saha N; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Oberti M; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Dolafi T; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • DiGianni L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Root EJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kong X; The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Bremer RC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
  • Santiago KM; A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Bojadzieva J; The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Barley D; Genomic Medicine, MAHSC, University of Manchester, Saint Mary's Hospital, Manchester, United Kingdom.
  • Novokmet A; Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Ketchum KA; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Nguyen N; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Jacob S; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Nichols KE; Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Schiffman JD; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Evans DG; Genomic Medicine, MAHSC, University of Manchester, Saint Mary's Hospital, Manchester, United Kingdom.
  • Achatz MI; Centro de Oncologia, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Strong LC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
  • Garber JE; The University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Ladwa SA; Data Coordinating Center, ESAC, Inc., Rockville, Maryland.
  • Malkin D; Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
  • Weitzel JN; City of Hope National Medical Center, Duarte, California. JWeitzel@coh.org.
Cancer Epidemiol Biomarkers Prev ; 29(5): 927-935, 2020 05.
Article en En | MEDLINE | ID: mdl-32156722
ABSTRACT

BACKGROUND:

The success of multisite collaborative research relies on effective data collection, harmonization, and aggregation strategies. Data Coordination Centers (DCC) serve to facilitate the implementation of these strategies. The utility of a DCC can be particularly relevant for research on rare diseases where collaboration from multiple sites to amass large aggregate datasets is essential. However, approaches to building a DCC have been scarcely documented.

METHODS:

The Li-Fraumeni Exploration (LiFE) Consortium's DCC was created using multiple open source packages, including LAM/G Application (Linux, Apache, MySQL, Grails), Extraction-Transformation-Loading (ETL) Pentaho Data Integration Tool, and the Saiku-Mondrian client. This document serves as a resource for building a rare disease DCC for multi-institutional collaborative research.

RESULTS:

The primary scientific and technological objective to create an online central repository into which data from all participating sites could be deposited, harmonized, aggregated, disseminated, and analyzed was completed. The cohort now include 2,193 participants from six contributing sites, including 1,354 individuals from families with a pathogenic or likely variant in TP53. Data on cancer diagnoses are also available. Challenges and lessons learned are summarized.

CONCLUSIONS:

The methods leveraged mitigate challenges associated with successfully developing a DCC's technical infrastructure, data harmonization efforts, communications, and software development and applications. IMPACT These methods can serve as a framework in establishing other collaborative research efforts. Data from the consortium will serve as a great resource for collaborative research to improve knowledge on, and the ability to care for, individuals and families with Li-Fraumeni syndrome.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Li-Fraumeni / Enfermedades Raras / Intercambio de Información en Salud / Cooperación Internacional Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Li-Fraumeni / Enfermedades Raras / Intercambio de Información en Salud / Cooperación Internacional Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article
...